JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Rumi, Elisa

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. [electronic resource] - Blood Mar 2014 - 1544-51 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2013-11-539098 doi


Adolescent
Adult
Aged
Aged, 80 and over
Alleles
Calreticulin--genetics
Cell Transformation, Neoplastic--genetics
Codon
Exons
Female
Granulocytes
Humans
Janus Kinase 2--genetics
Male
Middle Aged
Mutation
Myeloproliferative Disorders--genetics
Polycythemia Vera--genetics
Primary Myelofibrosis--genetics
Prognosis
Receptors, Thrombopoietin--genetics
Thrombocythemia, Essential--diagnosis
Thrombosis--genetics
Young Adult